Citi Pharma Limited

PSX-CPHL
Pakistan Stock Exchange
Healthcare Pharmaceuticals
Global Rank
#27391
Country Rank
#115
Market Cap
67.25 M
Price
0.292
Change (%)
0.71%
Volume
1.72 M

Citi Pharma Limited's latest marketcap:

67.25 M

As of 06/26/2025, Citi Pharma Limited's market capitalization has reached $67.25 M. According to our data, Citi Pharma Limited is the 27391th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 67.25 M
Revenue (ttm) 45.1 M
Net Income (ttm) 2.89 M
Shares Out 228.46 M
EPS (ttm) 0.01
Forward PE 18.02
Ex-Dividend Date n/a
Earnings Date 10/07/2025
Market Cap Chart
Data Updated: 06/26/2025

Citi Pharma Limited's yearly market capitalization.

Citi Pharma Limited has seen its market value drop from rs8.17 B to rs67.25 M since 2021, representing a total decrease of 99.18% and an annual compound decline rate (CAGR) of 74.75%.
Date Market Cap Change (%) Global Rank
06/26/2025 rs67.25 M 22.49% 27391
12/31/2024 rs15.56 B 186.9% 27322
12/29/2023 rs5.42 B -1.7% 33991
12/30/2022 rs5.52 B -32.47% 31609
12/31/2021 rs8.17 B 28067

Company Profile

About Citi Pharma Limited

Citi Pharma Limited is a leading pharmaceutical company based in Lahore, Pakistan. Established in 2012, the company specializes in the manufacturing and distribution of high-quality pharmaceutical, medical chemical, and botanical products.

Key Highlights

  • Industry: Pharmaceuticals & Healthcare
  • Founded: 2012
  • Headquarters: Lahore, Pakistan
  • Core Business: Production of pharmaceutical, medical chemical, and botanical products

With a commitment to innovation and quality, Citi Pharma Limited serves the healthcare needs of Pakistan while adhering to stringent industry standards.

Frequently Asked Questions

  • What is Citi Pharma Limited's (PSX-CPHL) current market cap?
    As of 06/26/2025, Citi Pharma Limited (including the parent company, if applicable) has an estimated market capitalization of $67.25 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • Citi Pharma Limited global market capitalization ranking is approximately 27391 as of 06/26/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.